Antimicrobial Resistance and the Repurposing of Primaquine: A Review of Design, Screening and Antibacterial Evaluation
Antimicrobial resistance is now among the most pressing threats to global healthcare. Infections that were once routinely treatable increasingly survive first-line therapy, while the discovery pipeline for genuinely novel antibacterial agents has slowed to a near halt. MRSA is linked to close to 50,000 deaths annually...